Lu-ning Sun

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.

Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.

Journal: European journal of clinical pharmacology

Published: October 05, 2025

Simultaneous Determination of Ripretinib and Its Desmethyl Metabolite in Human Plasma Using LC-MS/MS.

Simultaneous Determination of Ripretinib and Its Desmethyl Metabolite in Human Plasma Using LC-MS/MS.

Journal: Therapeutic drug monitoring

Published: January 21, 2024

Calcium signaling crosstalk between the endoplasmic reticulum and mitochondria, a new drug development strategies of kidney diseases.

Calcium signaling crosstalk between the endoplasmic reticulum and mitochondria, a new drug development strategies of kidney diseases.

Journal: Biochemical pharmacology

Published: January 12, 2024

Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.

Determination of caffeine, paraxanthine, theophylline and theobromine in premature infants by HILIC-MS/MS.

Journal: Bioanalysis

Published: February 24, 2023

LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.

LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.

Journal: Biomedical chromatography : BMC

Published: February 24, 2023

Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.

Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.

Journal: Therapeutic drug monitoring

Published: January 10, 2023

Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.

Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.

Journal: Molecules (Basel, Switzerland)

Published: November 15, 2022

Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.

Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.

Journal: Therapeutic drug monitoring

Published: October 06, 2022

LC-MS/MS methods to quantify HCP002 in human plasma and urine: applications in a pharmacokinetic study.

LC-MS/MS methods to quantify HCP002 in human plasma and urine: applications in a pharmacokinetic study.

Journal: Bioanalysis

Published: February 23, 2022

LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.

LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.

Journal: Journal of separation science

Published: February 04, 2022

Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the quantification of regadenoson in human plasma and its pharmacokinetic application.

Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the quantification of regadenoson in human plasma and its pharmacokinetic application.

Journal: Journal of separation science

Published: September 18, 2021

Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.

Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: August 17, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026